(Q82930367)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

mucopolysaccharidosis I

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Shunji Tomatsu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Adriana M Montaño

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Toshihiro Oguma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Vu Chi Dung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Talita Giacomet de Carvalho

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

María L Gutiérrez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Seiji Yamaguchi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yasuyuki Suzuki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Masaru Fukushi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nobuo Sakura

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Luis Barrera

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Kazuhiro Kida

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mitsuru Kubota

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tadao Orii

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

17 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inherited Metabolic Disease

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

141-150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20162367%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10545-009-9036-3

18 January 2020

exact match

0 references

cites work

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

1 reference

12 December 2020

Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry

1 reference

12 December 2020

Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice.

1 reference

12 December 2020

Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue.

1 reference

12 December 2020

Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease

1 reference

12 December 2020

Prediction of neuropathology in mucopolysaccharidosis I patients.

1 reference

12 December 2020

Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis I

1 reference

12 December 2020

Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography/turbo-ionspray ionization tandem mass spectrometry

1 reference

12 December 2020

Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses

1 reference

12 December 2020

Enzyme replacement therapy in a murine model of Morquio A syndrome.

1 reference

12 December 2020

Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns

1 reference

12 December 2020

Tandem mass spectrometry for the direct assay of enzymes in dried blood spots: application to newborn screening for mucopolysaccharidosis II (Hunter disease).

1 reference

12 December 2020

Discovery of a new biomarker for the mucopolysaccharidoses (MPS), dipeptidyl peptidase IV (DPP-IV; CD26), by SELDI-TOF mass spectrometry

1 reference

12 December 2020

Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests

1 reference

12 December 2020

Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS

1 reference

12 December 2020

The quantitative spectrophotometric estimation of total sulfated glycosaminoglycan levels. Formation of soluble alcian blue complexes.

1 reference

12 December 2020

Binding and detection of glycosaminoglycans immobilized on membranes treated with cationic detergents.

1 reference

12 December 2020

Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA.

1 reference

12 December 2020

Disease-specific markers for the mucopolysaccharidoses

1 reference

12 December 2020

Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease

1 reference

12 December 2020

Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases

1 reference

12 December 2020

Development of an assay for the detection of mucopolysaccharidosis type VI patients using dried blood-spots

1 reference

12 December 2020

Mucopolysaccharidosis type II--genotype/phenotype aspects

1 reference

12 December 2020

Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease

1 reference

12 December 2020

Newborn screening for lysosomal storage disorders

1 reference

12 December 2020

Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion.

1 reference

12 December 2020

Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

1 reference

12 December 2020

Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.

1 reference

12 December 2020

Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses

1 reference

12 December 2020

Enzyme replacement in a canine model of Hurler syndrome

1 reference

12 December 2020

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

12 December 2020

Heparin cofactor II–thrombin complex: A biomarker of MPS disease

1 reference

12 December 2020

Urinary glycosaminoglycan excretion quantified by an automated semimicro method in specimens conveniently transported from around the globe

1 reference

12 December 2020

Heparin cofactor II–thrombin complex in MPS I: A biomarker of MPS disease

1 reference

12 December 2020

Determination of monosaccharides and disaccharides in mucopolysaccharidoses patients by electrospray ionisation mass spectrometry.

1 reference

12 December 2020

Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapy

1 reference

12 December 2020

Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report

1 reference

12 December 2020

Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses

1 reference

12 December 2020

Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature

1 reference

12 December 2020

Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases

1 reference

12 December 2020

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

1 reference

12 December 2020

Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients

1 reference

12 December 2020

Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.

1 reference

12 December 2020

Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry

1 reference

12 December 2020

Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry

1 reference

12 December 2020

Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders

1 reference

12 December 2020